-
Sawai Launches Eight Generic Drugs with 23 Strengths
-
Upsher-Smith and Rafarm Announce Launch of Moxifloxacin Ophthalmic Solution, USP 0.5%
-
Sawai Reports FY2020 Financial Results
-
Sawai Group Holdings Announces Posting of Impairment Loss and Revision of Forecast at Sawai Pharmaceutical
-
Message from the Chairman and Group CEO
